Chemokine CCL2 and cytokine IL-1α were the only markers the concentrations of which were significantly different in the CSF of MS patients but not in the CSF of LNB or TBE patients when compared with the non-LNB controls (Additional file 2). This evidence concerns the gene CCL2 and myeloid sarcoma.